# DILTIAZEM HCI

NDC: 51662-1335
Generic name: DILTIAZEM HCI
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20181221

FDA application: ANDA078538

## Active ingredients

- DILTIAZEM HYDROCHLORIDE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1335"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1335
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7d8e8b1e-f67b-57d2-e053-2991aa0a8d12